Position in FBIO
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$188,496
+$10,494 QoQ
Shares Held
61,600
-3.4% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#3
of 7 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in FBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. FBIO ranks #9 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNKD |
Mannkind Corp
|
4,959,351 | $21,126,835 | |
| 2 | MRNA |
Moderna, Inc.
|
35,750 | $2,503,572 | |
| 3 | INCY |
Incyte Corp
|
7,045 | $798,621 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
190,562 | $699,362 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,257 | $395,796 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
8,753 | $341,454 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
548 | $272,208 | |
| 8 | EXEL |
Exelixis, Inc.
|
4,266 | $232,113 |
All Filings in FBIO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $188,496 | 61,600 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $178,002 | 63,800 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $277,611 | 75,850 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $305,250 | 82,500 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $173,073 | 93,050 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $136,422 | 87,450 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $165,039 | 81,300 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $99,035 | 68,300 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $106,618 | 62,350 | Shares | Sole | 2024-07-16 | |
| No filing history on record for this holder in this stock. | ||||||